Literature DB >> 7981074

Insulin and glucose status, tissue and plasma lipids in patients with tumours of the ovary or endometrium: possible dietary implications.

D Yam1, H Ben-Hur, A Fink, R Dgani, A Shani, A Eliraz, V Insler, E M Berry.   

Abstract

The relationship between tumour growth, insulin status, blood lipids and adipose linoleic acid (LA, reflecting long-term LA intake) was studied in 19 Jewish women suffering from early and advanced stages (ES and AS) of ovarian and endometrial tumours. Blood insulin in patients with ES tumours was four times higher than the control value in cancer-free subjects, but fell to normal levels at AS and after ES surgery (PES). Tumours and abdominal adipose tissue (AAT) had 4-6 and 1.4-1.7 times as much insulin as non-cancerous control organs. Serum total cholesterol (CHOL) and LDL-cholesterol were high at ES, dropped below normal at AS, but normalised at PES, while HDL-cholesterol increased after ES surgery. Linoleic acid in subcutaneous adipose tissue (SAT) was high in controls (26.4 + 1.5% of total fatty acids), but lower in cancer patients (20.5 + 3.7%, P < 0.05), while palmitic acid showed the opposite change. The results suggest mobilisation of glucose, cholesterol and linoleic acid for the supply of energy and structural lipids to rapidly multiplying tumour cells and possibly for prostaglandin synthesis. They also raise the question of whether the high linoleic acid intake by the Jewish population in Israel predisposes individuals to tumour development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981074      PMCID: PMC2033712          DOI: 10.1038/bjc.1994.470

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Environmental and nutritional factors significantly associated with cancer of the urinary tract among different ethnic groups.

Authors:  W A Bitterman; H Farhadian; C Abu Samra; D Lerner; H Amoun; D Krapf; U E Makov
Journal:  Urol Clin North Am       Date:  1991-08       Impact factor: 2.241

2.  Growth of a thymoma in diabetic mice treated with insulin.

Authors:  K Pavelić; M Slijepcević
Journal:  Eur J Cancer       Date:  1978-06       Impact factor: 9.162

3.  Insulin resistance in patients with colorectal cancer.

Authors:  G P Copeland; S J Leinster; J C Davis; L J Hipkin
Journal:  Br J Surg       Date:  1987-11       Impact factor: 6.939

4.  Abnormal insulin-receptor down regulation and dissociation of down regulation from insulin biological action in cultured human tumor cells.

Authors:  K G Mountjoy; G J Finlay; I M Holdaway
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

5.  Polyunsaturated fatty acids augment insulin secretion.

Authors:  C K Lardinois; G H Starich; E L Mazzaferri; A DeLett
Journal:  J Am Coll Nutr       Date:  1987-12       Impact factor: 3.169

6.  Insulin-cancer relationships: possible dietary implication.

Authors:  D Yam
Journal:  Med Hypotheses       Date:  1992-06       Impact factor: 1.538

7.  Enhancement of metastasis from a transplantable mouse mammary tumor by dietary linoleic acid.

Authors:  N E Hubbard; K L Erickson
Journal:  Cancer Res       Date:  1987-12-01       Impact factor: 12.701

Review 8.  Atherosclerosis in diabetes: the role of hyperinsulinemia.

Authors:  M W Stolar
Journal:  Metabolism       Date:  1988-02       Impact factor: 8.694

9.  Dietary fat, adipose tissue composition, and the development of carcinoma of the colon.

Authors:  E M Berry; J Zimmerman; M Peser; M Ligumsky
Journal:  J Natl Cancer Inst       Date:  1986-07       Impact factor: 13.506

  9 in total
  4 in total

1.  Development of a multimarker assay for early detection of ovarian cancer.

Authors:  Zoya Yurkovetsky; Steven Skates; Aleksey Lomakin; Brian Nolen; Trenton Pulsipher; Francesmary Modugno; Jeffrey Marks; Andrew Godwin; Elieser Gorelik; Ian Jacobs; Usha Menon; Karen Lu; Donna Badgwell; Robert C Bast; Anna E Lokshin
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

Review 2.  Cancer cachexia.

Authors:  Michael J Tisdale
Journal:  Langenbecks Arch Surg       Date:  2004-05-28       Impact factor: 3.445

Review 3.  Breast cancer: further metabolic-endocrine risk markers?

Authors:  B A Stoll
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Molecular characterization of lung dysplasia induced by c-Raf-1.

Authors:  Astrid Rohrbeck; Volker Steffen Müller; Jürgen Borlak
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.